Chengdu high-tech Medical Association will further build and integrate the innovation and development of the bio-pharmaceutical industry, accelerate the transformation of scientific and technological achievements in the bio-pharmaceutical industry, and make use of platform advantages, actively organize investors-china resources (Group) Co. , Ltd. and China Resources Pharmaceutical Group Co. , Ltd. , 2 high-quality project enterprises in our city to carry out in-depth exchange talks to promote cooperation opportunities.  November 16,2022, by the Chengdu high-tech Medical Association secretary-general, Medical Integration and innovation center director of Comrade Zeng bin entrusted,Bu Wei, deputy director of the Medical and Industrial Integration Collaborative Innovation Center of Chengdu Hi Tech Medical Association, together with Li Haitang, business director of the Great Health Group of the Strategic Management Department of China Resources (Group) Co., Ltd. and Ding Fan, director of the Investment Development Department of China Resources Pharmaceutical Group Co., Ltd., and other 8 people, made a field visit to Chengdu Biotech Co., Ltd.

  On November 18, 2022, Lin Fan, Deputy Secretary General of Chengdu Hi tech Medical Association and Deputy Director of the Medical Industry Integration and Collaborative Innovation Center, led a delegation of 10 people, including Li Haitang, Business Director of the Great Health Group of the Strategic Management Department of China Resources (Group) Co., Ltd., Ding Fan, Director of the Investment Development Department of China Resources Pharmaceutical Group Co., Ltd., and Guo Jiewei, Project Manager of the Management Committee of Chengdu Tianfu International Biological City, to make a field visit to Chengdu Anyong Dingye Biotechnology Co., Ltd.

  The Society led the delegation of China Resources (Group) Co., Ltd. and China Resources Pharmaceutical Group Co., Ltd. to visit the laboratories of the two companies successively, and learned about the production process, product quality control and R&D platform; They also exchanged and discussed with the two companies on the implementation of scientific and technological innovation projects and enterprise financial services, and the two companies introduced the product pipeline and enterprise development planning of their projects in detail, and clarified their needs in combination with their existing projects.

  Li Haitang, Business Director of the Great Health Group of the Strategic Management Department of China Resources (Group) Co., Ltd., and Ding Fan, Director of the Investment Development Department of China Resources Pharmaceutical Group Co., Ltd., spoke highly of the quality control and R&D capabilities of the two projects; It also explains that it is actively seeking cooperation projects to support the strategic development of the enterprise and ultimately achieve win-win results.

  Lin Fan, deputy secretary-general of Chengdu Hi tech Medical Association, said that the Society has always adhered to the working concept of "strengthening the grassroots and promoting transformation", and has taken promoting medical innovation drive and medical industry integration as its own responsibility. It is committed to providing full industry chain services for high-tech and biomedical research and development, promoting the transformation of high-quality projects, and realizing the desire to benefit the people.